|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM202463966 |
003 |
DE-627 |
005 |
20250212032342.0 |
007 |
cr uuu---uuuuu |
008 |
231223s2011 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2010.08.003
|2 doi
|
028 |
5 |
2 |
|a pubmed25n0675.xml
|
035 |
|
|
|a (DE-627)NLM202463966
|
035 |
|
|
|a (NLM)20956091
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Yu, Joyce E
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a High levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease
|
264 |
|
1 |
|c 2011
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 08.03.2011
|
500 |
|
|
|a Date Revised 05.11.2023
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2010 Elsevier Inc. All rights reserved.
|
520 |
|
|
|a Chronic granulomatous disease (CGD) and inflammatory bowel disease (IBD) have overlapping gastrointestinal manifestations. Serum antibodies to intestinal microbial antigens in IBD are thought to reflect a loss of tolerance in the setting of genetically encoded innate immune defects. CGD subjects studied here, with or without colitis, had considerably higher levels of ASCA IgA, ASCA IgG, anti-OmpC, anti-I2, and anti-CBir1, but absent to low pANCA, compared to IBD-predictive cutoffs. Higher antibody levels were not associated with a history of colitis. Except for higher ASCA IgG in subjects <18 years, antibody levels were not age-dependent. In comparison, 7 HIES subjects expressed negative to low antibody levels to all of these antigens; none had colitis. Our results suggest that markedly elevated levels of antimicrobial antibodies in CGD do not correlate with a history of colitis but may reflect a specific defect in innate immunity in the face of chronic antigenic stimulation
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, N.I.H., Extramural
|
650 |
|
4 |
|a Research Support, N.I.H., Intramural
|
650 |
|
7 |
|a Antibodies, Antineutrophil Cytoplasmic
|2 NLM
|
650 |
|
7 |
|a Antibodies, Bacterial
|2 NLM
|
650 |
|
7 |
|a Antibodies, Fungal
|2 NLM
|
650 |
|
7 |
|a CBir1 flagellin
|2 NLM
|
650 |
|
7 |
|a OmpC protein
|2 NLM
|
650 |
|
7 |
|a Porins
|2 NLM
|
650 |
|
7 |
|a Flagellin
|2 NLM
|
650 |
|
7 |
|a 12777-81-0
|2 NLM
|
700 |
1 |
|
|a De Ravin, Suk See
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Uzel, Gulbu
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Landers, Carol
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Targan, Stephan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Malech, Harry L
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Holland, Steven M
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Cao, Wenqing
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Harpaz, Noam
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Mayer, Lloyd
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Cunningham-Rundles, Charlotte
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 138(2011), 1 vom: 15. Jan., Seite 14-22
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:138
|g year:2011
|g number:1
|g day:15
|g month:01
|g pages:14-22
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2010.08.003
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 138
|j 2011
|e 1
|b 15
|c 01
|h 14-22
|